United States: ‘Tis The Season For Hospice Probe Edits – Be Ready

Palmetto GBA has announced a new non-cancer prepayment edit targeted at hospices with significant nursing home populations.  Many providers have been through similar non-cancer probe edits repeatedly, while for others this may be a new experience.  In this post, Sheppard Mullin reviews several important points for providers facing such edits (from any Medicare Administrative Contractor).

CMS is charged with paying only Medicare claims that are reasonable and necessary.  In structuring the benefit policies, CMS imposes many highly specific and detailed requirements (such as detailed face to face requirements discussed here).  In a prepayment edit, MACs will rely upon any error to deny payment, no matter how trifling.

Because CMS cannot conduct prepayment medical review on all claims, MAC's are instructed to target medical review resources to claims with a "significant potential to be non-covered" or that pose "significant risk to the Medicare program."  Medicare PIM § 3.2.1.  Medical review can be provider-specific where there is a "likelihood of sustained or high level of payment error."  For complex medical review, like hospice medical necessity, CMS requires a "high probability of aberrant billing practices" due to the higher cost and more subjective nature of complex claims analysis.  PIM § 3.4.2.

These requirements can help providers with a good prior track record avoid such edits.  Upon receipt of ADR requests, such providers can contact the MACs and urge withdrawal of the probe edit based upon their prior track record especially where, as in the new Palmetto edit, the edit is based on a general concept rather than provider specific facts.

In a prepayment probe edit, MACs will issue ADRs and review 20-40 claims at once for each affected provider.  The provider has 30 days to produce documentation; the MAC has 60 days from receipt to make a decision.  PIM §  Providers should take special care in reviewing, organizing, submitting, and tracking receipt of ADR packets.

Both of these provisions can lead to points of discussion:

  • Smaller Providers.  Because a prepayment edit defers revenue for providers for up to 90 days, providers face financial hardship from these edits.  For a small hospice, if the MAC initially selects 40 claims, this can often comprise 50% of  revenue.  The PIM instructs MACs to limit the "administrative burden on providers.  PIM § 3.2.2 A.  And, Congress has defined financial hardship as occurring where the circumstance affects as much as ten percent (10%) of  revenue.  42 U.S.C. § 1395ddd(f)(1)(B).  Providers can use this authority to advocate for smaller or staggered probe edit sampling.
  • Delayed Decision Making.  Non-cancer hospice probe edits often affect hundreds of providers, forcing the MAC to review thousands of complex claims within a short time (60 days).  MACs are often incapable of timely completing such review.  Providers can advocate for release of claims not timely decided.  (A provider who does not timely respond is subject to claim denial.  PIM § and (if MAC claims no documentation, provider has 15 days to supplement).)

On an initial claim determination, Congress requires CMS to provide "reasons" for any denial as well as notice of appeal rights (42 U.S.C. §1395ff; see Appeal Timeline Chart here).  But, in both regulation and the PIM, CMS differentiates between beneficiaries (entitled to "reasons" for any denial) and providers who are only entitled to "basis" by remittance advice coding.  42 C.F.R. § 405.921(b)(2); PIM § and 3.6.4.  In most cases then, providers facing these edits receive only a denial code.  These limited notice policies limits providers' ability to respond to denials and should be the subject of advocacy by provider representatives.  Such limited notice practices also mean that providers must carefully watch remittances to identify decisions.

MACs and other auditors will deny claims on any basis without assessing whether the deficiency is material or trifling.  Trifling denials (such as certifications missing benefit period dates) are regularly reversed by ALJs, who focus on medical necessity.  As detailed in prior posts, such denials are legally improper and should be challenged vigorously.

CMS itself has provided that responses to deficiencies should be "appropriate given the level of non-compliance," and yet full claim denial is the one response made to almost any probe edit deficiency.  The PIM fails to consider the alternative of a corrective action plan for technical deficiencies in a probe edit.  PIM § 3.7.  Although the PIM notes that it is not an "efficient" use of resources to deny claims that are "regularly reversed on appeal," CMS has taken no steps to suggest corrective action plan options to stem trifling payment denials.  PIM §3.7.4 (suggesting MACs track appeals).

PIM provisions now provide further detail on signature and dating requirements, as well as the potential to amend records. PIM §§ and  For instance, providers could face denials for illegible doctor signatures, but can potentially avoid this issue by providing a signature log for its staff, providing sample signatures and matching those to medical staff by printed names.  Also, providers are permitted to amend documentation before submission, for instance to add benefit period dates to certifications if missing, but are subject to certain requirements to call out these amendments (sign and date).

It is also important to note that MACs review hospice claims using LPNs and RNs, while initial decisions to certify patients are made by doctors and a team of nurses and staff.  Courts have been critical of second guessing subjective life expectancy decisions made by doctors.  See U.S. ex rel Wall v. Vista Hospice Care, Inc., 778 F. Supp. 2d 709, 718 (N.D. Tex. 2011) ("physician must use his clinical judgment to determine hospice eligibility, and... [a] complaint about the exercise of that judgment must be predicated on the presence of an objectively verifiable fact at odds with the exercise of that judgment, not a matter of subjective clinical analysis").

Because MACs cannot muster the resources that hospices do in making these decisions, medical necessity findings are quite often poorly reasoned and reversed on appeal (50%+ reversal rate for prosecuted appeals).  Even if denials are on medical necessity grounds, providers should strongly consider appeals.  As noted above, a provider's track record in prior edits is relevant to later administrative review – protect your reputation.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
17 Oct 2018, Conference, Los Angeles, United States

This interactive data simulation will help you prepare your company for a data breach. We will address how to handle tricky legal notice situations and multi-jurisdictional notice law by walking through a step-by-step experience.

17 Oct 2018, Other, Los Angeles, United States

​The recent overhaul of the U.S. tax code impacts nonprofits significantly, from reducing incentives for charitable giving to taxing certain executive compensation.

18 Oct 2018, Other, Los Angeles, United States

The World Wide Web was invented in 1990 by computer scientist Tim Berners-Lee. As of July 2018, out of a total population of 7.7 billion people on earth, 4.1 billion people were active on the Internet and 3.3 billion people were social media users, with China, India and the United States leading the way.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions